F. F. Şenol
{"title":"Determining the Possible Effects of Blood Groups on Covid-19 Positivity in Humans","authors":"F. F. Şenol","doi":"10.5505/ejm.2022.16680","DOIUrl":null,"url":null,"abstract":"Since COVID-19 disease spreads very rapidly in society, the effect of genetic blood types on people catching the disease should be investigated. In this study, the aim was to investigate whether there is a relationship between ABO and Rh blood group systems and COVID-19 disease, severity and frequency. The blood groups of 16913 patients treated with the diagnosis of COVID-19 between March 10, 2020 and March 31, 2021 and 23141 control cases were compared retrospectively. The blood group distributions of th e patients treated in the intensive care unit were examined. Among the COVID-19 positive patients, the percentage of patients with blood group A (45.04%) was statistically significantly higher than the percentage of patients with blood group O (26.69%), b lood group B (17.16%) and blood group AB (8.09%). The percentage of COVID-19 positive patients who were Rh positive (88.06%) was statistically significantly higher than the percentage who were Rh negative (11.93%). Among the COVID-19 patients, 7354 (43.48%) of 16913 patients were hospitalized and treated in the intensive care unit. The distribution of patients treated in the intensive care unit by blood group was blood group A 46.0%, blood group O 28.95%, blood group B 17.36%, and blood group AB 7.65%. In the intensive care unit, 6445 were Rh (+) (87.63%) and 909 were Rh (-) (12.36%). It was determined that the risk of COVID-19 disease is associated with ABO and Rh blood groups. We think that blood groups have an important role in the follow-up and treatment of COVID-19 disease. Copyright © 2022, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.","PeriodicalId":11407,"journal":{"name":"Eastern Journal of Medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eastern Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/ejm.2022.16680","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
确定血型对人类Covid-19阳性的可能影响
由于COVID-19在社会上传播非常迅速,因此应该调查遗传血型对感染者的影响。在这项研究中,目的是调查ABO和Rh血型系统与COVID-19疾病、严重程度和频率之间是否存在关系。回顾性比较2020年3月10日至2021年3月31日收治的16913例新冠肺炎患者与23141例对照患者的血型。对重症监护病房收治的5例患者进行血型分布分析。在COVID-19阳性患者中,A血型患者的比例(45.04%)显著高于O血型患者(26.69%)、b血型患者(17.16%)和AB血型患者(8.09%)。Rh阳性患者比例(88.06%)高于Rh阴性患者比例(11.93%),差异有统计学意义。在16913例新冠肺炎患者中,有7354例(43.48%)在重症监护病房住院治疗。重症监护病房就诊患者按血型分布依次为A血型46.0%、O血型28.95%、B血型17.36%、AB血型7.65%。重症监护病房Rh(+) 6445例(87.63%),Rh(-) 909例(12.36%)。确定COVID-19疾病的风险与ABO和Rh血型相关。我们认为血型在COVID-19疾病的随访和治疗中具有重要作用。版权所有©2022,郁祖库伊尔大学Tip Fakultesi。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。